ACI
ATRS

AMP Capital Investors’s Antares Pharma, Inc. ATRS Stock Holding History

AMP Capital Investors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,368
Closed -$66K – 1334
2020
Q4 		$66K Buy
+16,368
New +$53K ﹤0.01% 1236
2020
Q1 		– Sell
-75,960
Closed -$353K – 1251
2019
Q4 		$353K Buy
+75,960
New +$311K ﹤0.01% 1038

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

AMP Capital Investors's ATRS Position: Q1 2021 in Review

AMP Capital Investors sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 16,368 shares — an estimated $66K sold.

AMP Capital Investors first reported a position in ATRS in Q4 2019 and held it in 2 quarters. The position peaked at $353K in Q4 2019. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

  • AMP Capital Investors reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
  • AMP Capital Investors sold 16,368 Antares Pharma, Inc. shares in Q1 2021, an estimated $66K.
  • AMP Capital Investors first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 2 quarters.
  • AMP Capital Investors's Antares Pharma, Inc. position peaked at $353K in Q4 2019.
  • 171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on AMP Capital Investors's 13F filing for Q1 2021, filed 17 May 2021.